PDT Partners’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,189
Closed -$257K 1055
2021
Q4
$257K Buy
6,189
+123
+2% +$5.35K 0.02% 717
2021
Q3
$256K Buy
6,066
+466
+8% +$23.5K 0.02% 634
2021
Q2
$257K Hold
5,600
0.02% 648
2021
Q1
$262K Buy
+5,600
New +$272K 0.02% 649

Other funds holding NRC

PDT Partners's NRC Position: Q1 2022 in Review

PDT Partners sold out of NRC Health Common Stock (NRC) in Q1 2022, closing a stake of 6,189 shares — an estimated $257K sold.

PDT Partners first reported a position in NRC in Q1 2021 and held it in 4 quarters. The position peaked at $262K in Q1 2021. 116 funds tracked by Wall St. Rank hold NRC as of Q1 2022.

  • PDT Partners reported no remaining NRC Health Common Stock position as of Q1 2022 after selling out during the quarter.
  • PDT Partners sold 6,189 NRC Health Common Stock shares in Q1 2022, an estimated $257K.
  • PDT Partners first reported a position in NRC Health Common Stock in Q1 2021 and held it in 4 quarters.
  • PDT Partners's NRC Health Common Stock position peaked at $262K in Q1 2021.
  • 116 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2022.

Based on PDT Partners's 13F filing for Q1 2022, filed 16 May 2022.